AURKA and cancer: Notably, AURKA overexpression in cancer cells has also been implicated in activating a plethora of prosurvival oncogenic pathways including β‐catenin, NF‐κB, and AKT (Dar et al., 2008b, 2009; Katsha et al., 2013).